Annual Net Income
-$626.60 M
-$67.59 M-12.09%
December 31, 2023
Summary
- As of February 7, 2025, PTCT annual net profit is -$626.60 million, with the most recent change of -$67.59 million (-12.09%) on December 31, 2023.
- During the last 3 years, PTCT annual net income has fallen by -$188.44 million (-43.01%).
- PTCT annual net income is now -2127.55% below its all-time high of $30.90 million, reached on December 31, 2011.
Performance
PTCT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$106.65 M
-$7.47 M-7.54%
September 30, 2024
Summary
- As of February 7, 2025, PTCT quarterly net profit is -$106.65 million, with the most recent change of -$7.47 million (-7.54%) on September 30, 2024.
- Over the past year, PTCT quarterly net income has increased by +$26.32 million (+19.79%).
- PTCT quarterly net income is now -8497.95% below its all-time high of $1.27 million, reached on December 31, 2017.
Performance
PTCT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$453.20 M
+$26.32 M+5.49%
September 30, 2024
Summary
- As of February 7, 2025, PTCT TTM net profit is -$453.20 million, with the most recent change of +$26.32 million (+5.49%) on September 30, 2024.
- Over the past year, PTCT TTM net income has increased by +$188.50 million (+29.38%).
- PTCT TTM net income is now -6768.87% below its all-time high of -$6.60 million, reached on March 31, 2012.
Performance
PTCT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
PTCT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.1% | +19.8% | +29.4% |
| 3 y3 years | -43.0% | +19.8% | +29.4% |
| 5 y5 years | -389.2% | +19.8% | +29.4% |
PTCT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.6% | at low | -16.5% | +46.4% | at high | +29.4% |
| 5 y | 5-year | -149.1% | at low | -53.0% | +46.4% | -80.1% | +29.4% |
| alltime | all time | -2127.6% | at low | -8498.0% | +46.4% | -6768.9% | +29.4% |
PTC Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$106.65 M(+7.5%) | -$453.20 M(-5.5%) |
| Jun 2024 | - | -$99.18 M(+8.3%) | -$479.52 M(-17.2%) |
| Mar 2024 | - | -$91.58 M(-41.2%) | -$579.22 M(-7.6%) |
| Dec 2023 | -$626.60 M(+12.1%) | -$155.79 M(+17.2%) | -$626.60 M(-2.4%) |
| Sep 2023 | - | -$132.97 M(-33.1%) | -$641.70 M(+3.8%) |
| Jun 2023 | - | -$198.88 M(+43.1%) | -$618.05 M(+8.2%) |
| Mar 2023 | - | -$138.96 M(-18.7%) | -$571.25 M(+2.2%) |
| Dec 2022 | -$559.02 M(+6.7%) | -$170.89 M(+56.3%) | -$559.02 M(+5.2%) |
| Sep 2022 | - | -$109.31 M(-28.1%) | -$531.39 M(-4.4%) |
| Jun 2022 | - | -$152.09 M(+20.0%) | -$555.70 M(+6.5%) |
| Mar 2022 | - | -$126.73 M(-11.5%) | -$521.99 M(-0.4%) |
| Dec 2021 | -$523.90 M(+19.6%) | -$143.26 M(+7.2%) | -$523.90 M(+15.1%) |
| Sep 2021 | - | -$133.62 M(+12.9%) | -$454.99 M(+16.3%) |
| Jun 2021 | - | -$118.37 M(-8.0%) | -$391.06 M(-13.9%) |
| Mar 2021 | - | -$128.64 M(+73.0%) | -$454.12 M(+3.6%) |
| Dec 2020 | -$438.16 M(+74.2%) | -$74.35 M(+6.7%) | -$438.16 M(-0.8%) |
| Sep 2020 | - | -$69.69 M(-61.6%) | -$441.48 M(+2.2%) |
| Jun 2020 | - | -$181.43 M(+61.0%) | -$431.79 M(+47.8%) |
| Mar 2020 | - | -$112.69 M(+45.1%) | -$292.15 M(+16.1%) |
| Dec 2019 | -$251.58 M(+96.4%) | -$77.68 M(+29.5%) | -$251.58 M(+13.2%) |
| Sep 2019 | - | -$60.00 M(+43.6%) | -$222.23 M(+4.2%) |
| Jun 2019 | - | -$41.79 M(-42.1%) | -$213.20 M(+17.8%) |
| Mar 2019 | - | -$72.11 M(+49.2%) | -$180.93 M(+41.3%) |
| Dec 2018 | -$128.08 M | -$48.33 M(-5.2%) | -$128.08 M(+63.2%) |
| Sep 2018 | - | -$50.97 M(+435.4%) | -$78.48 M(+28.1%) |
| Jun 2018 | - | -$9.52 M(-50.6%) | -$61.25 M(-11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$19.26 M(-1616.8%) | -$69.21 M(-12.4%) |
| Dec 2017 | -$79.00 M(-44.4%) | $1.27 M(-103.8%) | -$79.00 M(-26.2%) |
| Sep 2017 | - | -$33.74 M(+93.1%) | -$107.07 M(-1.3%) |
| Jun 2017 | - | -$17.48 M(-39.9%) | -$108.50 M(-16.5%) |
| Mar 2017 | - | -$29.06 M(+8.4%) | -$129.93 M(-8.6%) |
| Dec 2016 | -$142.11 M(-16.6%) | -$26.80 M(-23.8%) | -$142.11 M(-14.5%) |
| Sep 2016 | - | -$35.17 M(-9.6%) | -$166.26 M(-4.6%) |
| Jun 2016 | - | -$38.91 M(-5.6%) | -$174.32 M(+0.3%) |
| Mar 2016 | - | -$41.23 M(-19.1%) | -$173.76 M(+1.9%) |
| Dec 2015 | -$170.45 M(+81.8%) | -$50.95 M(+17.9%) | -$170.45 M(+16.1%) |
| Sep 2015 | - | -$43.22 M(+12.7%) | -$146.77 M(+12.2%) |
| Jun 2015 | - | -$38.36 M(+1.2%) | -$130.83 M(+11.3%) |
| Mar 2015 | - | -$37.91 M(+39.0%) | -$117.57 M(+25.4%) |
| Dec 2014 | -$93.75 M(+81.8%) | -$27.27 M(-0.0%) | -$93.75 M(+11.1%) |
| Sep 2014 | - | -$27.28 M(+8.7%) | -$84.37 M(+37.2%) |
| Jun 2014 | - | -$25.10 M(+78.1%) | -$61.50 M(+20.6%) |
| Mar 2014 | - | -$14.10 M(-21.2%) | -$50.99 M(-1.1%) |
| Dec 2013 | -$51.57 M(+96.6%) | -$17.89 M(+305.0%) | -$51.57 M(+29.1%) |
| Sep 2013 | - | -$4.42 M(-69.7%) | -$39.96 M(-6.7%) |
| Jun 2013 | - | -$14.59 M(-0.7%) | -$42.84 M(+24.8%) |
| Mar 2013 | - | -$14.68 M(+134.1%) | -$34.32 M(+30.8%) |
| Dec 2012 | -$26.23 M(-184.9%) | -$6.27 M(-14.0%) | -$26.23 M(+31.4%) |
| Sep 2012 | - | -$7.30 M(+20.3%) | -$19.96 M(+57.6%) |
| Jun 2012 | - | -$6.07 M(-8.0%) | -$12.67 M(+92.0%) |
| Mar 2012 | - | -$6.60 M | -$6.60 M |
| Dec 2011 | $30.90 M | - | - |
FAQ
- What is PTC Therapeutics annual net profit?
- What is the all time high annual net income for PTC Therapeutics?
- What is PTC Therapeutics annual net income year-on-year change?
- What is PTC Therapeutics quarterly net profit?
- What is the all time high quarterly net income for PTC Therapeutics?
- What is PTC Therapeutics quarterly net income year-on-year change?
- What is PTC Therapeutics TTM net profit?
- What is the all time high TTM net income for PTC Therapeutics?
- What is PTC Therapeutics TTM net income year-on-year change?
What is PTC Therapeutics annual net profit?
The current annual net income of PTCT is -$626.60 M
What is the all time high annual net income for PTC Therapeutics?
PTC Therapeutics all-time high annual net profit is $30.90 M
What is PTC Therapeutics annual net income year-on-year change?
Over the past year, PTCT annual net profit has changed by -$67.59 M (-12.09%)
What is PTC Therapeutics quarterly net profit?
The current quarterly net income of PTCT is -$106.65 M
What is the all time high quarterly net income for PTC Therapeutics?
PTC Therapeutics all-time high quarterly net profit is $1.27 M
What is PTC Therapeutics quarterly net income year-on-year change?
Over the past year, PTCT quarterly net profit has changed by +$26.32 M (+19.79%)
What is PTC Therapeutics TTM net profit?
The current TTM net income of PTCT is -$453.20 M
What is the all time high TTM net income for PTC Therapeutics?
PTC Therapeutics all-time high TTM net profit is -$6.60 M
What is PTC Therapeutics TTM net income year-on-year change?
Over the past year, PTCT TTM net profit has changed by +$188.50 M (+29.38%)